Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
Daiichi Sankyo
Chubb
Fuji
Medtronic
McKesson

Generated: August 19, 2019

DrugPatentWatch Database Preview

Litigation Details for Sanofi-Aventis v. Sun Pharmaceutical Industries Ltd. (S.D.N.Y. 2008)

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Sanofi-Aventis v. Sun Pharmaceutical Industries Ltd. (S.D.N.Y. 2008)

Docket   Try a Free Trial Date Filed 2008-07-11
Court District Court, S.D. New York Date Terminated 2011-12-21
Cause 35:271 Patent Infringement Assigned To Sidney H. Stein
Jury Demand None Referred To
Parties BRISTOL-MYERS SQUIBB SANOFI PHARMACEUTICALS HOLDING PARTNERSHIP; SANOFI-AVENTIS; SANOFI-AVENTIS U.S. LLC; SUN PHARMA GLOBAL, INC.; SUN PHARMACEUTICAL INDUSTRIES LTD.
Patents 4,529,596; 4,847,265; 6,429,210
Attorneys Charles B. Klein; Colin C Heitzmann; Colin C. Heitzman; David Noah Greenwald; Evan R Chesler; John D. Murnane; John K. Hsu; Luke A. Connelly; Richard J Stark; Robert Louis Baechtold; William Ericson Solander
Link to Docket External link to docket
Small Molecule Drugs cited in Sanofi-Aventis v. Sun Pharmaceutical Industries Ltd.
The small molecule drug covered by the patents cited in this case is   Try a Free Trial .

Details for Sanofi-Aventis v. Sun Pharmaceutical Industries Ltd. (S.D.N.Y. 2008)

Date Filed Document No. Description Snippet Link To Document
2008-07-11 1 Complaint relates to a process for the prepara- 4,529,596 7/1985 Aubert et al 546/115 tion…the owner of United States Patent No. 4,847,265 ("the '265 Patent") (attached as Exhibit…. The '265 Patent was duly and legally issued on July 11,1989. The '265 Patent is exclusively…the owner of United States Patent No. 6,429,210 ("the '210 Patent") (attached as Exhibit… The '210 Patent was duly and legally issued on August 6, 2002. The '210 Patent is exclusively External link to document
2011-12-21 67 asserted in this action with respect to U.S. Patent Np. 6,429,210 should be and hereby are dismissed. This… with respect to U.S. Patent No. 6,429,210 should be and hereby are dismissed; … 21 December 2011 1:08-cv-06286 830 Patent None District Court, S.D. New External link to document
Date Filed Document No. Description Snippet Link To Document

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
Cipla
Harvard Business School
Medtronic
Baxter
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.